CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV

Hepatitis B remains a major global public health challenge, with particularly high prevalence in medically disadvantaged western Pacific and African regions. Although clinically available technologies for the qPCR detection of HBV are well established, research on point-of-care testing has not progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Ronghua, Long, Jinzhao, Yuan, Mingzhu, Zheng, Xue, Shen, Yue, Jin, Yuefei, Yang, Haiyan, Li, Hao, Chen, Shuaiyin, Duan, Guangcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125043/
https://www.ncbi.nlm.nih.gov/pubmed/34063629
http://dx.doi.org/10.3390/ijms22094842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125043/
https://www.ncbi.nlm.nih.gov/pubmed/34063629
http://dx.doi.org/10.3390/ijms22094842

Ejemplares similares